Neuropeptide Y receptor Y6

Neuropeptide Y receptor Y6 (NPY Y6) is a protein that in humans is encoded by the NPY6R gene. It belongs to the neuropeptide Y receptor family, which is a group of G protein-coupled receptors (GPCRs) involved in a variety of physiological processes including regulation of energy homeostasis, anxiety, and memory. The NPY Y6 receptor, in particular, has been the subject of research due to its potential implications in obesity and metabolic disorders.

Function

The NPY Y6 receptor is activated by neuropeptide Y (NPY), a 36 amino acid peptide that is widely distributed in the central nervous system (CNS) and is involved in various physiological processes. Upon activation, NPY Y6 receptors can influence food intake, energy expenditure, and glucose metabolism, making them a potential target for the treatment of obesity and type 2 diabetes. However, the exact role of the NPY Y6 receptor in these processes remains under investigation, as its expression and functionality appear to vary significantly among different species.

Gene and Expression

The NPY6R gene is located on chromosome 4 in humans. Unlike other members of the neuropeptide Y receptor family, the expression of NPY Y6 receptor is not well-characterized in humans due to the pseudogenization of its gene, meaning that it is present as a pseudogene and may not encode a functional protein in humans. In contrast, functional NPY Y6 receptors have been identified in other species, such as mice and rats, where they are expressed in various tissues including the brain, spleen, and intestines.

Clinical Significance

The potential role of NPY Y6 receptor in obesity and metabolic disorders has sparked interest in its pharmacological targeting. Studies in animal models suggest that blockade or genetic deletion of the NPY Y6 receptor can lead to reduced food intake and body weight, highlighting its potential as a therapeutic target. However, the absence of a functional NPY Y6 receptor in humans complicates the direct translation of these findings to human obesity treatment.

Research Directions

Current research on the NPY Y6 receptor is focused on understanding its physiological role in species where it is functional, with the aim of uncovering potential indirect pathways that could be targeted in humans. Additionally, studies are exploring the receptor's involvement in other physiological and pathological processes, such as anxiety disorders and neurodegeneration, to fully elucidate its functions and therapeutic potential.

See Also

• Neuropeptide Y
• G protein-coupled receptor
• Obesity
• Type 2 diabetes

References

This GPCR-related article is a stub. You can help WikiMD by expanding it.

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian